type here...

Latest news

Regulatory

FDA Delays Biohaven’s Approval Decision for Rare Disease Drug Troriluzole

The U.S. Food and Drug Administration (FDA) has postponed its decision on Biohaven Pharmaceuticals’ lead drug candidate, troriluzole, a...
Commercial

Pathos AI Secures $365 Million in Series D Funding to Accelerate AI-Powered Cancer Drug Development

Pathos AI, a clinical-stage biotech company leveraging artificial intelligence to revolutionize cancer treatment, has announced the successful close of...
Newsletter

Life Sciences Voice Top Five Newsletter

Welcome to this week’s edition of the Life Sciences Voice Top Five Newsletter, your go-to source for the latest...
Regulatory

Abeona Nets $155M in Voucher Sale After FDA Approval

Abeona Therapeutics has secured a $155 million deal from the sale of a Priority Review Voucher (PRV), just two...
Commercial

Eli Lilly Invests $250 Million to Strengthen Ties with Purdue University

Eli Lilly is deepening its investment in Indiana by...
Regulatory

FDA Clears First At-Home HPV and Cervical Cancer Screening Kit

The U.S. Food and Drug Administration has approved the...
Clinical

Vertex Presses Pause on CF Study, Reports Major Write-Down

Vertex Pharmaceuticals has announced a temporary pause in part of a clinical trial evaluating its cystic fibrosis (CF) candidate,...
Commercial

Eli Lilly Secures Rights to Alchemab’s Early-Stage ALS Drug in $415M Deal

Just four months after announcing a research collaboration, Eli Lilly is licensing its first drug candidate from British biotech...
Research & Development

New Data Positions Immutep’s Immunotherapy Combo as First-Line Option for PD-L1-Negative HNSCC

Immutep, the developer of eftilagimod alpha, has reported promising overall survival (OS) results that could pave the way for...
Clinical

J&J Gene Therapy Treatment For Vision Loss Fails to Meet Primary Endpoints

Johnson & Johnson acquired the entire rights to a...
Clinical

Pfizer’s PD-1 Inhibitor Shows Mixed Results in Bladder Cancer Trial

Pfizer has announced detailed results from its Phase 3...
Clinical

Medtronic Highlights Improved Results with Affera PFA Technology

Medtronic has announced encouraging clinical outcomes from two studies evaluating its pulsed field ablation (PFA) technologies. These studies focused...
Newsletter

Life Sciences Voice Top Five Newsletter

Welcome to this week’s edition of the Life Sciences Voice Top Five Newsletter, your go-to source for the latest...
Manufacturing

Roche offers $50 billion to US pharma production in response to the tariff threat

Roche, the drugmaker giant, announced its interest in investing $50 billion over five years in new and existing facilities...
Commercial

Pathos AI Secures $365 Million in Series D Funding to Accelerate AI-Powered Cancer Drug Development

Pathos AI, a clinical-stage biotech company leveraging artificial intelligence...
Editorial Team -
Commercial

$1.5 Billion Cancer Drug Facility to Be Built by AstraZeneca in Singapore

AstraZeneca is reportedly planning to build a $1.5 billion...
Commercial

Teleflex Restructures Amidst €760 Million Biotronik Deal, Paving the Way for Two Independent Businesses

Teleflex has announced plans to restructure its operations by...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team -

Elon Musk Announces Neuralink’s Second Brain-Computer Chip Implantation in a Patient

Neuralink, founded by Elon Musk, revealed that it has placed its device in the...
Editorial Team -

Regulatory

Regulatory

FDA Delays Biohaven’s Approval Decision for Rare Disease Drug Troriluzole

The U.S. Food and Drug Administration (FDA) has postponed...
Editorial Team -
Commercial

Pathos AI Secures $365 Million in Series D Funding to Accelerate AI-Powered Cancer Drug Development

Pathos AI, a clinical-stage biotech company leveraging artificial intelligence...
Newsletter

Life Sciences Voice Top Five Newsletter

Welcome to this week’s edition of the Life Sciences...
Regulatory

Abeona Nets $155M in Voucher Sale After FDA Approval

Abeona Therapeutics has secured a $155 million deal from...
Regulatory

FDA and CDC Recommend Halting Chikungunya Vaccine Use in Older Adults

Following similar actions by France and the European Union,...

Research & Development

Market Access

Manufacturing

Rovi’s Expansion in Pharmaceutical Production with Moderna

The Laboratorios Farmacéuticos Rovi and Moderna partnership has recently...
Manufacturing

Bristol Myers Squibb Expands Irish Campus with $400M Investment in Drug Manufacturing

Bristol Myers Squibb (BMS) has disclosed a significant infusion...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Regulatory

FDA Delays Biohaven’s Approval Decision for Rare Disease Drug Troriluzole

The U.S. Food and Drug Administration (FDA) has postponed...
Editorial Team -
Manufacturing

Chinese CRO GemPharmatech Expands in San Diego as FDA Reevaluates Animal Testing Requirements

The Chinese contract research organization (CRO) GemPharmatech continues to...
Editorial Team -
Newsletter

Life Sciences Voice Top Five Newsletter

Welcome to this week’s edition of the Life Sciences...
Editorial Team -

Editor Picks

Must Read

Hot Topics

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Contact us: reachout(at)lifescivoice.com

Follow Us

© Copyright - Life Sciences Voice